1. Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization–embryo transfer 
Chung-Hoon Kim, M.D., Hee-Dong Chae, M.D., Yoon-Seok Chang, M.D. 
Fertility and Sterility 
Volume 71, Issue 4, Pages (April 1999)
DOI: /S (98)

2. FIGURE 1
Comparison of serum concentrations of growth hormone (GH) (A) and insulin-like growth factor-1 (IGF-1) (B) between the placebo and pyridostigmine groups. COH = controlled ovarian hyperstimulation. □ = the placebo group; ■ = the pyridostigmine group. ∗P<.05 (vs. the placebo group); †P<.01 (vs. the placebo group).
Fertility and Sterility  , DOI: ( /S (98) )

3. FIGURE 2
Comparison of intrafollicular concentrations of growth hormone (GH) (A) and insulin-like growth factor-1 (IGF-1) (B) between the placebo and pyridostigmine groups. ∗P<.05 (vs. the placebo group); †P<.001 (vs. the placebo group).
Fertility and Sterility  , DOI: ( /S (98) )